HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy

As PI3K/Akt signaling is frequently deregulated in a wide variety of human tumors, PI3K inhibitors are an emerging class of drugs for cancer treatment. The monitoring of the drug behavior and distribution in the biological system can play an important role for targeted therapy and provide informatio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Lee, Ju-Hee, Jung, Kyung Hee, Lee, Hyunseung, Son, Mi Kwon, Yun, Sun-Mi, Ahn, Sung-Hoon, Lee, Kyeong-Ryoon, Lee, Soyoung, Kim, Donghee, Hong, Sungwoo, Hong, Soon-Sun
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2014
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259414/
https://ncbi.nlm.nih.gov/pubmed/25338206
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky